These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 324261

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Disodium Ascorbyl Phytostanyl Phosphates (FM-VP4) reduces plasma cholesterol concentration, body weight and abdominal fat gain within a dietary-induced obese mouse model.
    Looije NA, Risovic V, Stewart DJ, Debeyer D, Kutney J, Wasan KM.
    J Pharm Pharm Sci; 2005 Aug 24; 8(3):400-8. PubMed ID: 16401390
    [Abstract] [Full Text] [Related]

  • 26. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr 24; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 27. A spermine-coupled cholesterol metabolite from the shark with potent appetite suppressant and antidiabetic properties.
    Zasloff M, Williams JI, Chen Q, Anderson M, Maeder T, Holroyd K, Jones S, Kinney W, Cheshire K, McLane M.
    Int J Obes Relat Metab Disord; 2001 May 24; 25(5):689-97. PubMed ID: 11360152
    [Abstract] [Full Text] [Related]

  • 28. Novel selective antagonist of the cannabinoid CB1 receptor, MJ15, with prominent anti-obesity effect in rodent models.
    Chen W, Tang H, Liu H, Long L, Gong Z, Zheng J, Chi M, Xie Y, Zheng Z, Li S, Wang L.
    Eur J Pharmacol; 2010 Jul 10; 637(1-3):178-85. PubMed ID: 20380831
    [Abstract] [Full Text] [Related]

  • 29. Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.
    Coccurello R, Caprioli A, Ghirardi O, Conti R, Ciani B, Daniele S, Bartolomucci A, Moles A.
    Psychopharmacology (Berl); 2006 Jul 10; 186(4):561-71. PubMed ID: 16758241
    [Abstract] [Full Text] [Related]

  • 30. Pharmacological approaches to treating the obese patient.
    Bray GA, Greenway FL.
    Clin Endocrinol Metab; 1976 Jul 10; 5(2):455-79. PubMed ID: 821680
    [Abstract] [Full Text] [Related]

  • 31. Ventromedial hypothalamic knife-cut lesions in rats resistant to dietary obesity.
    Oku J, Bray GA, Fisler JS, Schemmel R.
    Am J Physiol; 1984 Jun 10; 246(6 Pt 2):R943-8. PubMed ID: 6742173
    [Abstract] [Full Text] [Related]

  • 32. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice.
    Cho AS, Jeon SM, Kim MJ, Yeo J, Seo KI, Choi MS, Lee MK.
    Food Chem Toxicol; 2010 Mar 10; 48(3):937-43. PubMed ID: 20064576
    [Abstract] [Full Text] [Related]

  • 33. Pyrrolidin-2-one derivatives may reduce body weight in rats with diet-induced obesity.
    Dudek M, Knutelska J, Bednarski M, Nowiński L, Zygmunt M, Kazek G, Mordyl B, Głuch-Lutwin M, Zaręba P, Kulig K, Sapa J.
    Eur J Pharmacol; 2016 Apr 05; 776():146-55. PubMed ID: 26896778
    [Abstract] [Full Text] [Related]

  • 34. Visceral fat accumulation and vascular complications associated with VMH lesioning of spontaneously non-insulin-dependent diabetic GK rat.
    Yoshida S, Yamashita S, Tokunaga K, Yamane M, Shinohara E, Keno Y, Nishida M, Kotani K, Shimomura I, Kobayashi H, Nakamura T, Miyagawa J, Kameda-Takemura K, Odaka H, Ikeda H, Matsuzawa Y.
    Int J Obes Relat Metab Disord; 1996 Oct 05; 20(10):909-16. PubMed ID: 8910094
    [Abstract] [Full Text] [Related]

  • 35. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
    Clapper JR, Athanacio J, Wittmer C, Griffin PS, D'Souza L, Parkes DG, Roth JD.
    Eur J Pharmacol; 2013 Jan 05; 698(1-3):292-8. PubMed ID: 23178527
    [Abstract] [Full Text] [Related]

  • 36. Improvement on lipid metabolic disorder by 3'-deoxyadenosine in high-fat-diet-induced fatty mice.
    Niu YJ, Tao RY, Liu Q, Tian JY, Ye F, Zhu P, Zhu HB.
    Am J Chin Med; 2010 Jan 05; 38(6):1065-75. PubMed ID: 21061461
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Effects of acetylenedicarboxylate: relationship between decreased carcass lipid and increased liver size and lean body weight.
    Arch JR, Cornish S, Green A, Cawthorne MA.
    Int J Obes; 1979 Jan 05; 3(4):289-99. PubMed ID: 393646
    [Abstract] [Full Text] [Related]

  • 39. A water-soluble extract from Cucurbita moschata shows anti-obesity effects by controlling lipid metabolism in a high fat diet-induced obesity mouse model.
    Choi H, Eo H, Park K, Jin M, Park EJ, Kim SH, Park JE, Kim S.
    Biochem Biophys Res Commun; 2007 Aug 03; 359(3):419-25. PubMed ID: 17548058
    [Abstract] [Full Text] [Related]

  • 40. Novel effects of the cannabinoid inverse agonist AM 251 on parameters related to metabolic syndrome in obese Zucker rats.
    Merroun I, Sánchez-González C, Martínez R, López-Chaves C, Porres JM, Aranda P, Llopis J, Galisteo M, Zarzuelo A, Errami M, López-Jurado M.
    Metabolism; 2013 Nov 03; 62(11):1641-50. PubMed ID: 23932644
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.